BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

FEI Company Announces Magellan Extreme Resolution SEM for Life Sciences


12/7/2010 12:32:42 PM

Hillsboro, Ore./December 7, 2010?FEI Company (NASDAQ: FEIC), a leading instrumentation company providing electron microscope systems for applications in research and industry, today announced the Magellan™ extreme resolution scanning electron microscope (SEM) optimized specifically for life science imaging. The first of its kind, the Magellan SEM enables life science researchers and cell biologists to actually view the entire organization of a cell in its natural, fully-hydrated state. The Magellan’s workflow solution, which includes cryogenic sample preparation and handling, is a repeatable, optimized process to provide the highest quality imaging and analysis results.

“We have been using the Magellan for a year now, and we can conclude that a big step forward has been made in sub-nanometer imaging in plant, agricultural, nutrition and food sciences,” said Adriaan van Aelst, manager, Wageningen Electron Microscopy Centre, Wageningen University, The Netherlands. “The Magellan, together with the implemented cryo system, is an indispensable imaging and analysis tool in our microscopy laboratory. All the users and clients are surprised about the high image quality and stability of the system.”

The Magellan is the only family of SEMs that provides high-throughput, sub-nanometer resolution even at low accelerating voltages, while maintaining the flexibility and ease-of-use that are characteristic of SEM technology. This combination of ultra low-voltage imaging and high-resolution power, along with cryogenic sample preparation and handling, is essential for imaging fragile biological systems, such as cells, viruses, plants, and other living species.

According to Dominique Hubert, FEI’s vice president and general manager for the Life Sciences Division, “FEI raised the bar with the release of the Magellan for materials science and electronics applications in 2008. Now, the addition of a fully integrated workflow for cryo sample preparation and handling in this new Magellan for Life Sciences allows cell biologists to apply the same powerful imaging capabilities to biological systems in their natural state.”

Cryogenic sample preparation and handling are critical in life science applications in order to avoid the harsh chemical drying and fixing procedures otherwise required to make biological samples compatible with the vacuum environment of the SEM. The Magellan cryo workflow starts with vitrification, a freezing process so fast that the water in the sample solidifies without causing visible crystals, thus avoiding the damage normally associated with ice formation.

Once the vitrified sample is transferred to the vacuum chamber, the Magellan delivers sub-nanometer imaging resolution over the full range of accelerating voltages-even below 1kV to 30kV. Operation at low voltages is particularly important to reduce damage to delicate biological samples, improve resolution on light element materials, and increase the surface specificity of the imaging signal. The Magellan delivers all of these benefits without giving up any of the simplicity or flexibility of a conventional SEM.

The Magellan for Life Sciences is available for ordering immediately. For more information, please visit http://www.fei.com.

About FEI

FEI (Nasdaq: FEIC) is a leading diversified scientific instruments company. It is a premier provider of electron- and ion-beam microscopes and tools for nanoscale applications across many industries: industrial and academic materials research, life sciences, semiconductors, data storage, natural resources and more. With more than 60 years of technological innovation and leadership, FEI has set the performance standard in transmission electron microscopes (TEM), scanning electron microscopes (SEM) and DualBeams™, which combine a SEM with a focused ion beam (FIB). FEI’s imaging systems provide 3D characterization, analysis and modification/prototyping with resolutions down to the sub-Ångström (one-tenth of a nanometer) level. FEI’s NanoPorts in North America, Europe and Asia provide centers of technical excellence where its world-class community of customers and specialists collaborate. FEI has approximately 1800 employees and sales and service operations in more than 50 countries around the world. More information can be found at: www.fei.com.

FEI Safe Harbor Statement This news release contains forward-looking statements that include statements regarding the performance capabilities and benefits of the Magellan XHR SEM. Factors that could affect these forward-looking statements include but are not limited to failure of the product or technology to perform as expected and achieve anticipated results, unexpected technology problems and our ability to manufacture, ship and deliver the tools or software as expected. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES